Health Naturally, LLC graphic header
Four Things You Should Know About Prostate Cancer
In This Issue
Can Drugs Prevent Prostate Cancer?
Studies Often Leave out Bad News
Watchful Waiting is Safe
Guidelines Recommend Active Surveillance
Mortality Low During Active Surveillance
Prostate Cancer Screening
PSA Screening is "Public Health Disaster"
PSA Velocity May Help Identify Insignificant Prostate Cancer
Prostate Cancer Drug Boosts Heart Disease Risk
Keep Your Prostate Healthy
Legislation and Legal Issues
Website News
A Survey
Join our list or forward this email to a friend.
Join Our Mailing List

Forward this email 
Dr. Jim's Book
Your Prostate, Your Libido, Your Life book cover
Page Links
April 15, 2010
There are many items that men should know about prostate cancer, but perhaps the three most important ones are that:
  1. Drugs that claim to reduce your risk of getting Prostate Cancer can significantly increase your risk of other, more serious problems.  
  2. Most Prostate Cancer is slow-growing and  non-agressive, and thus, does not always need to be agressively treated with radiation, seeds or surgery.Prostate Cancer is perhaps the most over-treated illness in Western society.
  3. Screening for Prostate Cancer, particularly with the PSA test, is highly inaccurate, and often results in unnecessary invasive procedures that offer little benefit to the patient.
  4. Treatment for Prostate Cancer can cause serious side effects that are sometimes more life-altering than the disease. 
The articles in this newsletter are from several sources, and provide, what I believe is a more realistic approach a man would want to evaluate if he was recently diagnosed with Prostate Cancer.

Can Drugs Prevent Prostate Cancer?
If you worry about getting prostate cancer, you would have to live on another planet to be unaware of the hype surrounding the use of prescription drugs like dutasteride (Avodart) or finasteride (Proscar) for preventing prostate cancer. This article explores the truth behind the hype and includes links to the original report in the NEJM as well as links to some other views.
Urology Treatment Studies Often Leave out Bad News
A new analysis of the medical literature shows that reports of study results of new urological treatments frequently don't include full information about their potential harms.
Watchful waiting for prostate cancer is safe
Another new study, published in the Journal of Clinical Oncology, finds that patients with early-stage, slow-growing prostate cancers are not taking a risk if they choose to let their doctors simply "keep an eye" on their disease rather than treat it right away.  
Active Surveillance Now Prominent in NCCN Prostate Cancer Guidelines.
For the first time, the National Comprehensive Cancer Network's (NCCN) practice guidelines for prostate cancer recommend the use of active surveillance as the sole initial treatment - not just an option - for many men with prostate cancer.
Prostate Cancer-Specific Mortality Extremely Low During Active Surveillance
Active surveillance of prostate cancer, with intervention offered for progressive disease, appears to be safe even for intermediate-risk disease in men over the age of 70, findings from a prospective cohort study suggest.

Prostate Cancer Screening: 50 Percent False Positives
As many as 50 percent of all prostate cancer diagnoses may be cases of over-diagnosis, according to a study published in the British Medical Journal. Over-diagnosis refers to the detection of a cancer that, if left untreated, would never have any negative effects on a person's life.

PSA Discoverer Says PSA Screening is "Public Health Disaster"
Screening men for prostate-specific antigen (PSA), the most commonly used tool for detecting prostate cancer, has become a "hugely expensive public health disaster," says the researcher who discovered PSA in 1970.

PSA Velocity May Help Identify Insignificant Prostate Cancer
The speed at which PSA rises (or PSA velocity - PSAV), is increasingly recognized as a marker of potentially lethal prostate cancer.  It also has the added advantage of predicting the likelihood that a given patient's cancer is insignificant, researchers say.
Prostate cancer drug boosts heart disease risk
A common prostate cancer treatment known as hormone ablation therapy may significantly increase men's risk of heart problems, according to a study conducted by researchers from King's College London.

Keep your Prostate Healthy
Saw Palmetto/Pygeum Prostate Support
Saw Palmetto combined with African Pygeum is the premier product for supporting good prostate health.

Our Saw Palmetto Pygeum Plus Softgels are made with the highest quality European Standardized Extracts of Saw Palmetto and Pygeum. Pumpkin Seed Oil, Nettle Root Extract, Lycopene and L-OptiZinc work synergistically to enhance the proven benefits of Saw Palmetto and Pygeum for healthy prostate support. 
      Click Here to Buy    

Legislation and Legal Issues

Well Folks. Brace yourself for the FDA's newest crazyness! I can't make this stuff up.  Fiction does not do it justice! So here it is. After reading it, I hope you will take some action. 

In the latest volley of the US Food and Drug Administration's bizarre war on scientific freedom of speech, the FDA has sent a Warning Letter to the president and CEO of Diamond Foods stating that the firm's packages of shelled walnuts are "in violation of the Federal Food, Drug, and Cosmetic Act."

Diamond Foods, a processor and distributor of nuts, dared to list some of the health benefits of walnuts on its website. The FDA says that the walnuts are being "promoted for conditions that cause them to be drugs because these products are intended for use in the prevention, mitigation, and treatment of disease." 

So where does this end? It ends when citizens band together and protest this ludicrous violation of free speech!

Finally - Legislation to Protect Your Right to Know About the Science Behind Supplements!

The "Free Speech About Science Act", H.R. 4913. This landmark legislation protects basic free speech rights, ends censorship of science, and enables the natural health products community to share peer-reviewed scientific findings about natural health products with the public.
If this bill passes, it has the potential to transform the healthcare field. It will legally allow health care practitioners like myself to freely educate the public about the real science behind natural health. This is a small bill with vast potential leverage.
Please click on the link below to read the entire article and use the link below  (or the one with the article) to contact your representative and ask him or her to cosponsor and support the "Free Speech about Science Act"!
       Contact Your Representative                                           Read More

Website News

As I mentioned in my last newsletter, my new website, 
is operational and its entry page is now the home page for both websites.  Thus, you will be able to seamlessly move from men's to women's issues and back. Some of the pages, like the newsletter archive and the products section are shared between both sites.  The shared parts of the two websites are the Books, Products, and News sections, and these are now operational. 
Ladies take note that I am still working hard on the "Female Issues" section of the website, and hope to have it up and running within the next few weeks.
To search for information or a product, simply click the "Site Search" button located at the top left of every main page. You will then see a search screen where you can enter a keyword (or keywords) to search the site for. Direct links to pages found allow you to quickly view information on many topics. 
Our  newsletter archive contains copies of all previous newsletters. A link to the archive is on every main page of the website just below the newsletter sign-up box and also in the "page links" section of each newsletter issue. 

A Survey

If you would like to have an input into what I put in this newsletter, please email me directly.  This is your newsletter and I want to provide you with information that is useful and helpful to you. So, send me an email with your suggestions and I will try to address subjects you want in future issues.
As always, if you enjoy this newsletter (or hate it), feel free to contact me with your comments.  And, if you really like it, please forward it to a friend using the "Forward Email" link below.
Jim Occhiogrosso
     Forward This Newsletter to a Friend
Four Things You Should Know About Prostate Cancer